Protalix
On the pulse of digital health in Israel
What if diseases that currently have no effective treatment could be relieved using proteins that plant cells make? Protalix, a NASDAQ-traded biopharmaceutical company, is developing and commercializing drugs manufactured with their proprietary platform.
What did we do?
They needed a fresh look and feel—so that’s where we stepped in. We overhauled their website and communication materials. We brought a modern look to two websites (corporate and a site for Phase III studies), prepared their clinical presentations, and helped with the collateral for the exhibitions. Always under extremely tight schedules, but always a pleasure to do.
Pitch Decks
Website
An elaborate corporate website for a NASDAQ-traded company
Click on the image to scroll the full page
Website
With a comprehensive investor section too
Click on the image to scroll the full page
Pitch Decks
Used in multiple pitches, worldwide.
Protalix (NASDAQ:PLX) has been working with CandenSee and Chen Sirkis for quite a few years. They have developed and designed our new corporate web site, a patient website for our Phase III studies for Fabry Disease, in addition to the creation of various corporate and medical communication pieces (medical presentations, conference posters, and more). Chen’s high professionalism and his medical marcom expertise is evident from the first interaction and throughout our work with him. Chen has the ability to work in tight timelines, be creative and not lose sight of detail. Especially in the life science world, where precision and creativity need to be combined, Chen is the right person to work with.
Ronen Rosenberg
VP Commercial and Product Planning
Get in Touch and let's talk Medical
You can contact us in multiple ways: By email, filling the form on the right, and LinkedIn. Let's start!